Search

everythinglearnresearchcommunity

for

Search:↓

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Certain Dibenzo derivatives may help treat prostate cancer.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

Mutations in certain receptors can cause diseases and offer new treatment options.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

Eplerenone, a mineralocorticoid receptor antagonist, was found to promote hair growth in human hair follicles.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Certain gene variations are linked to severe acne in Egyptian patients and could guide treatment choices.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Excess androgens may cause PCOS, not just be a symptom.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Scopolin and scopoletin from Merremia peltata leaves may help treat hair loss and showed promising results in rabbit tests.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.